Doseology Sciences (FRA:VU70) NonCurrent Deferred Liabilities: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VU70 Doseology Sciences Inc FRA:VU70
35 GF Score
Price €0.09
GF Value €0.13
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences NonCurrent Deferred Liabilities?

Doseology Sciences FRA:VU70 -0.55% 35 NonCurrent Deferred Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:VU70 with a GF Score™ of 35/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Doseology Sciences's non-current deferred liabilities for the quarter that ended in Mar. 2026 was €0.00 Mil.

Doseology Sciences NonCurrent Deferred Liabilities Related Terms

Doseology Sciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Doseology Sciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doseology Sciences NonCurrent Deferred Liabilities Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Doseology Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:VU70
35GF Score
Doseology Sciences Inc FRA:VU70
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €0.00 Mil mean?
Doseology Sciences (FRA:VU70) has a NonCurrent Deferred Liabilities of €0.00 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Doseology Sciences and its competitors.
Is Doseology Sciences' NonCurrent Deferred Liabilities too high?
Doseology Sciences' current NonCurrent Deferred Liabilities is €0.00 Mil. Overall, Doseology Sciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' NonCurrent Deferred Liabilities compare to VRTX and REGN?
Doseology Sciences' NonCurrent Deferred Liabilities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Doseology Sciences and its competitors. Doseology Sciences's current NonCurrent Deferred Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Doseology Sciences (FRA:VU70) has a current NonCurrent Deferred Liabilities of €0.00 Mil. The stock's GF Value™ is €0.13, compared to a current price of €0.09 — trading 30% below its estimated fair value. The current NonCurrent Deferred Liabilities is €0.00 Mil. Doseology Sciences' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Doseology Sciences (FRA:VU70), the current NonCurrent Deferred Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (FRA:VU70) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of €0.09 is trading 30% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:VU70:

  • NonCurrent Deferred Liabilities: €0.00 Mil
  • GF Value™: €0.13 vs. price of €0.09 (30% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the FRA:VU70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges DOSEF:USAMOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
35GF Score

Get the complete analysis for FRA:VU70

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.13
GF Value